选择性雄激素受体调节剂所致药物性肝损伤
Drug-Induced Liver Injury by Selective Androgenic Receptor Modulators.
作者信息
Flores Joan Ericka, Chitturi Shivakumar, Walker Sarah
机构信息
Canberra Hospital Garran ACT Australia.
Australian National University Acton ACT Australia.
出版信息
Hepatol Commun. 2020 Jan 3;4(3):450-452. doi: 10.1002/hep4.1456. eCollection 2020 Mar.
Abstract
Selective androgenic receptor modulators (SARMs) have not been approved by the U.S. Food and Drug Administration but they are heavily promoted as alternatives to androgenic anabolic steroids. We present two cases of liver injury associated with SARMs.
摘要
选择性雄激素受体调节剂（SARMs）尚未获得美国食品药品监督管理局的批准，但它们作为雄激素合成代谢类固醇的替代品被大力推广。我们报告两例与SARMs相关的肝损伤病例。
相似文献
1
Drug-Induced Liver Injury by Selective Androgenic Receptor Modulators.选择性雄激素受体调节剂所致药物性肝损伤
Hepatol Commun. 2020 Jan 3;4(3):450-452. doi: 10.1002/hep4.1456. eCollection 2020 Mar.
2
Selective Androgen Receptor Modulators: An Emerging Liver Toxin.选择性雄激素受体调节剂：一种新兴的肝毒素。
J Clin Transl Hepatol. 2023 Feb 28;11(1):188-196. doi: 10.14218/JCTH.2022.00207. Epub 2022 Nov 4.
3
Comparative safety evaluation of selective androgen receptor modulators and anabolic androgenic steroids.选择性雄激素受体调节剂与合成代谢雄激素类固醇的比较安全性评估
Expert Opin Drug Saf. 2015;14(11):1773-85. doi: 10.1517/14740338.2015.1094052. Epub 2015 Sep 24.
4
Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications.选择性雄激素受体调节剂：当前知识与临床应用。
Sex Med Rev. 2019 Jan;7(1):84-94. doi: 10.1016/j.sxmr.2018.09.006. Epub 2018 Nov 30.
5
Selective Androgen Receptor Modulator-Induced Liver Injury in Active Duty Male.现役男性中选择性雄激素受体调节剂所致肝损伤
Mil Med. 2023 Jul 22;188(7-8). doi: 10.1093/milmed/usac039. Epub 2022 Mar 7.
6
Novel Uses for the Anabolic Androgenic Steroids Nandrolone and Oxandrolone in the Management of Male Health.合成代谢雄激素类固醇诺龙和氧雄龙在男性健康管理中的新用途。
Curr Urol Rep. 2016 Oct;17(10):72. doi: 10.1007/s11934-016-0629-8.
7
Drug-Induced Liver Injury From Enobosarm (Ostarine), a Selective Androgen Receptor Modulator.选择性雄激素受体调节剂恩杂鲁胺（奥施力）所致药物性肝损伤
ACG Case Rep J. 2021 Jan 7;8(1):e00518. doi: 10.14309/crj.0000000000000518. eCollection 2021 Jan.
8
Pharmacodynamics of selective androgen receptor modulators.选择性雄激素受体调节剂的药效学
J Pharmacol Exp Ther. 2003 Mar;304(3):1334-40. doi: 10.1124/jpet.102.040840.
9
Profiling of anabolic androgenic steroids and selective androgen receptor modulators for interference with adrenal steroidogenesis.分析合成代谢雄激素和选择性雄激素受体调节剂对肾上腺类固醇生成的干扰。
Biochem Pharmacol. 2020 Feb;172:113781. doi: 10.1016/j.bcp.2019.113781. Epub 2019 Dec 27.
10
Selective androgen receptor modulators: the future of androgen therapy?选择性雄激素受体调节剂：雄激素治疗的未来？
Transl Androl Urol. 2020 Mar;9(Suppl 2):S135-S148. doi: 10.21037/tau.2019.11.02.
引用本文的文献
1
The Potential of SARMs and Antimyostatin Agents in Addressing Lean Body Mass Loss From GLP-1 Agonists: A Literature Review.选择性雄激素受体调节剂（SARMs）和抗肌生成抑制素药物在解决GLP-1激动剂引起的瘦体重损失方面的潜力：一项文献综述
J Diabetes. 2025 Aug;17(8):e70119. doi: 10.1111/1753-0407.70119.
2
Silent Threats to the Liver: Acute Hepatotoxicity Attributed to Selective Androgen Receptor Modulators (SARMs).肝脏的隐匿威胁：归因于选择性雄激素受体调节剂（SARMs）的急性肝毒性
Cureus. 2025 Jun 7;17(6):e85500. doi: 10.7759/cureus.85500. eCollection 2025 Jun.
3
Ligandrol lowers endurance and negatively affects lipid and hormonal profile of male rats.利胍多胺降低雄性大鼠的耐力，并对其脂质和激素水平产生负面影响。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar 15. doi: 10.1007/s00210-025-04028-8.
4
Abuse of Anabolic-Androgenic Steroids as a Social Phenomenon and Medical Problem-Its Potential Negative Impact on Reproductive Health Based on 50 Years of Case Report Analysis.作为一种社会现象和医学问题的合成代谢雄激素类固醇滥用——基于50年病例报告分析其对生殖健康的潜在负面影响
J Clin Med. 2024 Oct 2;13(19):5892. doi: 10.3390/jcm13195892.
5
Illegal Use of Testosterone and Other Anabolic-Androgenic Steroids in the Population of Amateur Athletes in Wrocław, Poland-An Unfavorable Lifestyle Trend in the Population of Men of Reproductive Age.波兰弗罗茨瓦夫业余运动员群体中睾酮及其他合成代谢雄激素类固醇的非法使用——生殖年龄男性群体中一种不良的生活方式趋势
J Clin Med. 2024 Jun 26;13(13):3719. doi: 10.3390/jcm13133719.
6
Ostarine blunts the effect of endurance training on submaximal endurance in rats.Ostarine 削弱了耐力训练对大鼠亚极量耐力的影响。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Sep;397(9):6523-6532. doi: 10.1007/s00210-024-03030-w. Epub 2024 Mar 7.
7
Severe liver injury following use of RAD-140, a selective androgen receptor modulator, for body building.使用选择性雄激素受体调节剂RAD-140进行健身后出现严重肝损伤。
Aust Prescr. 2024 Feb;47(1):26-28. doi: 10.18773/austprescr.2024.004.
8
Selective androgen receptor modulator use and related adverse events including drug-induced liver injury: Analysis of suspected cases.选择性雄激素受体调节剂的使用及相关不良事件，包括药物性肝损伤：疑似病例分析。
Eur J Clin Pharmacol. 2024 Feb;80(2):185-202. doi: 10.1007/s00228-023-03592-3. Epub 2023 Dec 7.
9
Androgen Receptor and Cardiovascular Disease: A Potential Risk for the Abuse of Supplements Containing Selective Androgen Receptor Modulators.雄激素受体与心血管疾病：滥用含选择性雄激素受体调节剂的补充剂的潜在风险。
Nutrients. 2023 Jul 26;15(15):3330. doi: 10.3390/nu15153330.
10
Systematic Review of Safety of Selective Androgen Receptor Modulators in Healthy Adults: Implications for Recreational Users.健康成年人中选择性雄激素受体调节剂安全性的系统评价：对娱乐性使用者的启示。
J Xenobiot. 2023 May 10;13(2):218-236. doi: 10.3390/jox13020017.
本文引用的文献
1
Safety, Pharmacokinetic, and Pharmacodynamic Evaluation After Single and Multiple Ascending Doses of a Novel Selective Androgen Receptor Modulator in Healthy Subjects.健康受试者单次及多次递增剂量新型选择性雄激素受体调节剂后的安全性、药代动力学和药效学评价。
Clin Ther. 2016 Jun;38(6):1401-1416. doi: 10.1016/j.clinthera.2016.03.025. Epub 2016 Apr 13.
2
Causality assessment for suspected DILI during clinical phases of drug development.药物研发临床阶段疑似药物性肝损伤的因果关系评估。
Drug Saf. 2014 Nov;37 Suppl 1(Suppl 1):S47-56. doi: 10.1007/s40264-014-0185-4.
3
ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury.ACG 临床指南：药物性肝损伤的诊断与管理。
Am J Gastroenterol. 2014 Jul;109(7):950-66; quiz 967. doi: 10.1038/ajg.2014.131. Epub 2014 Jun 17.
4
Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial.依诺羟司他对癌症患者肌肉减少症及身体机能的影响：一项双盲、随机对照 2 期试验。
Lancet Oncol. 2013 Apr;14(4):335-45. doi: 10.1016/S1470-2045(13)70055-X. Epub 2013 Mar 14.
5
The safety, pharmacokinetics, and effects of LGD-4033, a novel nonsteroidal oral, selective androgen receptor modulator, in healthy young men.LGD-4033，一种新型非甾体口服、选择性雄激素受体调节剂，在健康年轻男性中的安全性、药代动力学和作用。
J Gerontol A Biol Sci Med Sci. 2013 Jan;68(1):87-95. doi: 10.1093/gerona/gls078. Epub 2012 Mar 28.
6
The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial.选择性雄激素受体调节剂GTx-024（恩杂鲁胺）可改善健康老年男性和绝经后女性的瘦体重及身体功能：一项双盲、安慰剂对照II期试验的结果
J Cachexia Sarcopenia Muscle. 2011 Sep;2(3):153-161. doi: 10.1007/s13539-011-0034-6. Epub 2011 Aug 2.
Zotero 插件